ASPET's grassroots congressional education effort informs ASPET members how to become effective public advocates for biomedical research.  Learn how ASPET's Advocacy Outreach program can visit your department and help graduate students, post-docs, and faculty at your institution become more effective advocates for biomedical science research... Read More

A groundbreaking study by Jaini et al. recently demonstrated that prophylactic immunization against a breast cancer associated antigen can prevent tumor development... [8/31/2010] Read More

Antineoplastic therapy using anthracyclines (e.g., Doxorubicin) is limited by cardiotoxicity, but results by Koka et al suggest that prophylactic treatment with tadalafil might be able to limit this toxicity... [8/26/2010] Read More

Thanks to efforts by Hibah Awwad and Badr Mostafa, the ASPET Neuropharmacology Division now has its own blog and a presence on Facebook... [8/16/2010] Read More

NIH has announced three new funding opportunities of interest to biomedical research scientists:  Tranformative Research Projects Awards Program, the 2011 Pioneer Awards, and New Innovator Awards Program. Read More

The Senate Appropriations Committee gave final approval to the Labor HHS Education Subcommittee spending bill that included $32.007 billion for NIH in FY 2011.  This funding level equals the president's budget request and the House Subcommittee approved bill.  Read More

We asked you to tell us which things you feel are lacking in current Pharmacology Graduate education. At least two clear themes seemed to emerge... [7/12/2010] Read More

Robert J. Lefkowitz will give the Norman Weiner Lecture at EB 2011. Read More

A recent article in Newsweek by Sharon Begley and Mary Carmichael calls attention to the decline over recent years in the number of new drugs introduced into medical practice. They suggest that NIH funding priorities should be targeted more directly towards the support of the pre-clinical and clinical studies required for the introduction of promising drug candidates into the clinic, arguing that the return on investment in NIH has been ‘approximately as satisfying’ for taxpayers and patients as the return on public investment in the AIG bailout. Read More

Pharmacology is a key integrative medical science discipline.  In the following article, Myron Toews discusses educational opportunities offered through ASPET and NIGMS in integrated organ systems approaches to drug development.  All graduate students and others interested in careers relating to drug development should consider these opportunities. Read More

This week ASPET has offered written testimony in support of a $37 billion FY 2011 NIH budget to the House Labor/Health and Human Services Appropriations Subcommittee. The following article by Jim Bernstein provides the background to this testimony, clearly depicting the difficult political and economic environment under which we will be operating in the near future. Read More

Over the last month of two I seem to have been particularly burdened with mandatory training courses and other regulatory requirements related to the conduct of research in my laboratory -- annual radiation safety training, prevention of sexual harassment training, whistleblower protection training, human research protection training, animal research protocol submissions and modifications. Read More

 The 2010 World Congress in Pharmacology to be held in Copenhagen in July is organized around a series of focused conferences each integrating recent basic and clinical research on a discrete topic in 2 or 3 day program within the main Congress schedule. The topics for all the conferences look very interesting, but one that caught my eye is on ion channelopathies (FC12: Ion channelopathies: new windows on complex disease and therapy). Read More